Treatment of disorders secondary to organic impairments
US6696495B2 · kind B2 · utility
6Cited by
23References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 6, 2002 |
| Grant date | Feb 24, 2004 |
| Priority date | — |
| Expiry date | Mar 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.